HIV and American cutaneous leishmaniasis in the state of Sergipe: a study of the dissemination spectrum of co-infection

Detalhes bibliográficos
Autor(a) principal: Lima, Bruno José Santos
Data de Publicação: 2021
Outros Autores: Sandes, Maylla Fontes, Aragão, Matheus Todt, Batista, Gilmara Carvalho, Araújo, Dante Costa de, Santos, José Abimael da Silva, Rezende, Mateus Lenier, Gonçalves, Hélder Santos, Melo, Leonardo Santos, Vieira, Caroline Cordeiro
Tipo de documento: Artigo
Idioma: por
Título da fonte: Scire Salutis
Texto Completo: https://sustenere.inf.br/index.php/sciresalutis/article/view/5699
Resumo: In patients co-infected with HIV, American cutaneous leishmaniasis (ATL) commonly becomes widespread, in addition to presenting atypical and more severe manifestations due to immunosuppression. In these patients, the disease is characterized by multiple atypical lesions infested by parasites, affecting various body segments, and poor response to standard treatment, with a high rate of recurrence. The present study elucidates a description of a case admitted to the Hospital de Urgências de Sergipe (HUSE), with diagnostic and conduct analysis based on the literature referring to LTA-HIV co-infection. It is a JBA, 34 years old, male, HIV positive and with a previous diagnosis of pulmonary tuberculosis, in regular use of antiretroviral therapy and COXCIP, admitted to HUSE in 2018 with productive cough, yellowish discharge, daily fever and dyspnea on exertion for a long time. 2 weeks. He had hyperchromic macular lesions on the face and crusted ulcers with elevated edges of varying sizes in the upper limbs and trunk, diagnosed with ACL via biopsy of the lesions after negative serological test rk39 by immunosuppression. He denied regular use of prophylaxis for pneumocystosis and mycobacteria. Antibiotic therapy and a nasal O2 catheter were started. It is assumed, therefore, that the deviation from the Th1 cell response to the humoral Th2 type response in HIV patients is favorable to the spread of intracellular organisms such as leishmania. However, this clinical-immunological behavior of co-infection is poorly described in the literature. Still, J.B.A. showed an excellent therapeutic response to the use of liposomal amphotericin. The report of this case alerts to the clinical spectrum of co-infection and to a viable treatment option, especially in Sergipe, whose epidemiological expansion of diseases is evident.
id ESS-1_7beb99564573395ad2ff9979030894df
oai_identifier_str oai:ojs.pkp.sfu.ca:article/5699
network_acronym_str ESS-1
network_name_str Scire Salutis
repository_id_str
spelling HIV and American cutaneous leishmaniasis in the state of Sergipe: a study of the dissemination spectrum of co-infectionHIV e Leishmaniose tegumentar americana no estado de Sergipe: um estudo do espectro disseminado da coinfecçãoHIVLeishmanioseCoinfecçãoHIVLeishmaniasisCoinfectionIn patients co-infected with HIV, American cutaneous leishmaniasis (ATL) commonly becomes widespread, in addition to presenting atypical and more severe manifestations due to immunosuppression. In these patients, the disease is characterized by multiple atypical lesions infested by parasites, affecting various body segments, and poor response to standard treatment, with a high rate of recurrence. The present study elucidates a description of a case admitted to the Hospital de Urgências de Sergipe (HUSE), with diagnostic and conduct analysis based on the literature referring to LTA-HIV co-infection. It is a JBA, 34 years old, male, HIV positive and with a previous diagnosis of pulmonary tuberculosis, in regular use of antiretroviral therapy and COXCIP, admitted to HUSE in 2018 with productive cough, yellowish discharge, daily fever and dyspnea on exertion for a long time. 2 weeks. He had hyperchromic macular lesions on the face and crusted ulcers with elevated edges of varying sizes in the upper limbs and trunk, diagnosed with ACL via biopsy of the lesions after negative serological test rk39 by immunosuppression. He denied regular use of prophylaxis for pneumocystosis and mycobacteria. Antibiotic therapy and a nasal O2 catheter were started. It is assumed, therefore, that the deviation from the Th1 cell response to the humoral Th2 type response in HIV patients is favorable to the spread of intracellular organisms such as leishmania. However, this clinical-immunological behavior of co-infection is poorly described in the literature. Still, J.B.A. showed an excellent therapeutic response to the use of liposomal amphotericin. The report of this case alerts to the clinical spectrum of co-infection and to a viable treatment option, especially in Sergipe, whose epidemiological expansion of diseases is evident.Em pacientes co-infectados por HIV, a Leishmaniose tegumentar americana (LTA) comumente se torna disseminada, além de apresentar manifestações atípicas e mais graves, devido à imunossupressão. Nestes pacientes, a doença é caracterizada por múltiplas lesões atípicas infestadas por parasitos, acometendo vários segmentos corporais, e má resposta ao tratamento padrão, com alta taxa de recidiva. O presente estudo elucida uma descrição de caso admitido no Hospital de Urgências de Sergipe (HUSE), com análise de diagnóstico e conduta baseada na literatura referente à coinfecção LTA-HIV. Trata-se de J.B.A., 34 anos, sexo masculino, HIV positivo e com diagnóstico anterior de Tuberculose pulmonar, em uso regular de terapia antirretroviral e COXCIP, admitido no HUSE em 2018 com tosse produtiva, secreção amarelada, febre diária e dispneia aos esforços há 2 semanas. Apresentava lesões maculares hipercrômicas em face e úlcero-crostosas de bordas elevadas com variados tamanhos em membros superiores e tronco, diagnosticadas LTA via biópsia das lesões após negativação do teste sorológico rk39 por imunossupressão. Negava uso regular de profilaxias para pneumocistose e micobactérias. Iniciou-se antibioticoterapia e cateter nasal de O2. Supõe-se, portanto, que o desvio da resposta celular tipo Th1 para a humoral tipo Th2 no portador de HIV seja favorável à disseminação de organismos intracelulares como a leishmania. Entretanto, esse comportamento clínico-imunológico da coinfecção é pouco descrito na literatura. Ainda assim, J.B.A. apresentou excelente resposta terapêutica ao uso de Anfotericina Lipossomal. O relato desse caso alerta para o espectro clínico da coinfecção e para uma opção de tratamento viável, sobretudo em Sergipe, cuja expansão epidemiológica das doenças é evidente.Sustenere Publishing2021-06-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://sustenere.inf.br/index.php/sciresalutis/article/view/569910.6008/CBPC2236-9600.2021.003.0016Scire Salutis; Vol. 11 No. 3 (2021): Scire Salutis - Jun, Jul, Ago, Set 2021; 126-129Scire Salutis; Vol. 11 Núm. 3 (2021): Scire Salutis - Jun, Jul, Ago, Set 2021; 126-129Scire Salutis; v. 11 n. 3 (2021): Scire Salutis - Jun, Jul, Ago, Set 2021; 126-1292236-9600reponame:Scire Salutisinstname:Companhia Brasileira de Produção Científica (CBPC)instacron:ESSporhttps://sustenere.inf.br/index.php/sciresalutis/article/view/5699/3057Copyright (c) 2021 Scire Salutishttp://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccessLima, Bruno José SantosSandes, Maylla FontesAragão, Matheus TodtBatista, Gilmara CarvalhoAraújo, Dante Costa deSantos, José Abimael da SilvaRezende, Mateus LenierGonçalves, Hélder SantosMelo, Leonardo SantosVieira, Caroline Cordeiro2023-01-04T20:16:52Zoai:ojs.pkp.sfu.ca:article/5699Revistahttps://sustenere.co/index.php/sciresalutisONGhttps://sustenere.co/index.php/sciresalutis/oai||carlos@arvore.org.br2236-96002236-9600opendoar:2023-01-04T20:16:52Scire Salutis - Companhia Brasileira de Produção Científica (CBPC)false
dc.title.none.fl_str_mv HIV and American cutaneous leishmaniasis in the state of Sergipe: a study of the dissemination spectrum of co-infection
HIV e Leishmaniose tegumentar americana no estado de Sergipe: um estudo do espectro disseminado da coinfecção
title HIV and American cutaneous leishmaniasis in the state of Sergipe: a study of the dissemination spectrum of co-infection
spellingShingle HIV and American cutaneous leishmaniasis in the state of Sergipe: a study of the dissemination spectrum of co-infection
Lima, Bruno José Santos
HIV
Leishmaniose
Coinfecção
HIV
Leishmaniasis
Coinfection
title_short HIV and American cutaneous leishmaniasis in the state of Sergipe: a study of the dissemination spectrum of co-infection
title_full HIV and American cutaneous leishmaniasis in the state of Sergipe: a study of the dissemination spectrum of co-infection
title_fullStr HIV and American cutaneous leishmaniasis in the state of Sergipe: a study of the dissemination spectrum of co-infection
title_full_unstemmed HIV and American cutaneous leishmaniasis in the state of Sergipe: a study of the dissemination spectrum of co-infection
title_sort HIV and American cutaneous leishmaniasis in the state of Sergipe: a study of the dissemination spectrum of co-infection
author Lima, Bruno José Santos
author_facet Lima, Bruno José Santos
Sandes, Maylla Fontes
Aragão, Matheus Todt
Batista, Gilmara Carvalho
Araújo, Dante Costa de
Santos, José Abimael da Silva
Rezende, Mateus Lenier
Gonçalves, Hélder Santos
Melo, Leonardo Santos
Vieira, Caroline Cordeiro
author_role author
author2 Sandes, Maylla Fontes
Aragão, Matheus Todt
Batista, Gilmara Carvalho
Araújo, Dante Costa de
Santos, José Abimael da Silva
Rezende, Mateus Lenier
Gonçalves, Hélder Santos
Melo, Leonardo Santos
Vieira, Caroline Cordeiro
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Lima, Bruno José Santos
Sandes, Maylla Fontes
Aragão, Matheus Todt
Batista, Gilmara Carvalho
Araújo, Dante Costa de
Santos, José Abimael da Silva
Rezende, Mateus Lenier
Gonçalves, Hélder Santos
Melo, Leonardo Santos
Vieira, Caroline Cordeiro
dc.subject.por.fl_str_mv HIV
Leishmaniose
Coinfecção
HIV
Leishmaniasis
Coinfection
topic HIV
Leishmaniose
Coinfecção
HIV
Leishmaniasis
Coinfection
description In patients co-infected with HIV, American cutaneous leishmaniasis (ATL) commonly becomes widespread, in addition to presenting atypical and more severe manifestations due to immunosuppression. In these patients, the disease is characterized by multiple atypical lesions infested by parasites, affecting various body segments, and poor response to standard treatment, with a high rate of recurrence. The present study elucidates a description of a case admitted to the Hospital de Urgências de Sergipe (HUSE), with diagnostic and conduct analysis based on the literature referring to LTA-HIV co-infection. It is a JBA, 34 years old, male, HIV positive and with a previous diagnosis of pulmonary tuberculosis, in regular use of antiretroviral therapy and COXCIP, admitted to HUSE in 2018 with productive cough, yellowish discharge, daily fever and dyspnea on exertion for a long time. 2 weeks. He had hyperchromic macular lesions on the face and crusted ulcers with elevated edges of varying sizes in the upper limbs and trunk, diagnosed with ACL via biopsy of the lesions after negative serological test rk39 by immunosuppression. He denied regular use of prophylaxis for pneumocystosis and mycobacteria. Antibiotic therapy and a nasal O2 catheter were started. It is assumed, therefore, that the deviation from the Th1 cell response to the humoral Th2 type response in HIV patients is favorable to the spread of intracellular organisms such as leishmania. However, this clinical-immunological behavior of co-infection is poorly described in the literature. Still, J.B.A. showed an excellent therapeutic response to the use of liposomal amphotericin. The report of this case alerts to the clinical spectrum of co-infection and to a viable treatment option, especially in Sergipe, whose epidemiological expansion of diseases is evident.
publishDate 2021
dc.date.none.fl_str_mv 2021-06-22
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://sustenere.inf.br/index.php/sciresalutis/article/view/5699
10.6008/CBPC2236-9600.2021.003.0016
url https://sustenere.inf.br/index.php/sciresalutis/article/view/5699
identifier_str_mv 10.6008/CBPC2236-9600.2021.003.0016
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://sustenere.inf.br/index.php/sciresalutis/article/view/5699/3057
dc.rights.driver.fl_str_mv Copyright (c) 2021 Scire Salutis
http://creativecommons.org/licenses/by-nc-nd/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 Scire Salutis
http://creativecommons.org/licenses/by-nc-nd/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sustenere Publishing
publisher.none.fl_str_mv Sustenere Publishing
dc.source.none.fl_str_mv Scire Salutis; Vol. 11 No. 3 (2021): Scire Salutis - Jun, Jul, Ago, Set 2021; 126-129
Scire Salutis; Vol. 11 Núm. 3 (2021): Scire Salutis - Jun, Jul, Ago, Set 2021; 126-129
Scire Salutis; v. 11 n. 3 (2021): Scire Salutis - Jun, Jul, Ago, Set 2021; 126-129
2236-9600
reponame:Scire Salutis
instname:Companhia Brasileira de Produção Científica (CBPC)
instacron:ESS
instname_str Companhia Brasileira de Produção Científica (CBPC)
instacron_str ESS
institution ESS
reponame_str Scire Salutis
collection Scire Salutis
repository.name.fl_str_mv Scire Salutis - Companhia Brasileira de Produção Científica (CBPC)
repository.mail.fl_str_mv ||carlos@arvore.org.br
_version_ 1793890278344491008